Panitumumab versus cetuximab in combination with irinotecan in refractory metastatic colorectal cancer.
Braghiroli MIFM, Filho DSRS, Fagundes JGM, Mendoza EZ, Neffa MFBV, Campos KS, da Fonseca LG, Bonadio RC, Talans A, Braghiroli OFM, Mathias-Machado MC, Sabbaga J, Moniz CMV, Hoff PMG.
Braghiroli MIFM, et al. Among authors: fagundes jgm.
Cancer Treat Res Commun. 2025 Jan 9;42:100867. doi: 10.1016/j.ctarc.2025.100867. Online ahead of print.
Cancer Treat Res Commun. 2025.
PMID: 39799855
Free article.